drugset / Trial / NCT03825146
The Effects of AMPC in the Treatments of Refractory or Relapsed AML
NaSingle-groupOpen-labelTreatment
Summary
A private trial for evaluating the overall response rate contributed by AMPC in AML in refractory or relapsed AML
Timeline
- Start
- 2019-01-04
- Primary completion
- 2021-01
- Completion
- 2021-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Autologous Multi-lineage Potential Cells | Unknown | 1e+08 cells | Intravenous |